JWN
60
3
PYPL
45
-7
DE
46
-3
TDC
70
5
BA
52
3
AES
41
-2
CNP
47
-2
PLD
50
-5
GOOGL
58
2
SO
59
-5
FE
37
-5
BXP
60
-2
MU
43
3
VLO
30
-3
ED
40
-6
DUK
40
-7
HD
44
-5
BBY
38
-2
PRGO
43
4
ROK
52
-2
JWN
60
3
PYPL
45
-7
DE
46
-3
TDC
70
5
BA
52
3
AES
41
-2
CNP
47
-2
PLD
50
-5
GOOGL
58
2
SO
59
-5
FE
37
-5
BXP
60
-2
MU
43
3
VLO
30
-3
ED
40
-6
DUK
40
-7
HD
44
-5
BBY
38
-2
PRGO
43
4
ROK
52
-2
Financhill
Back

Spyre Therapeutics Stock Predictions

Gold Set to Skyrocket as Fed Slashes Rates

Click here for the details on this incredible opportunity.
Buy
76

SYRE
Spyre Therapeutics

Last Price:
34.38
Seasonality Move:
10.02%

7 Day Trial

ALL ACCESS PASS

$ 7

AI DIVIDENDS: No. 1 Way to Collect Passive Income

Click here to get it for free.

Spyre Therapeutics Stock Forecast

  • Over the next 52 weeks, Spyre Therapeutics has on average historically risen by 11.9% based on the past 8 years of stock performance.
  • Spyre Therapeutics has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Spyre Therapeutics Stock Undervalued?
    The current Spyre Therapeutics [SYRE] share price is $33.80. The Score for SYRE is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
  • SYRE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Spyre Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Spyre Therapeutics has on average historically risen by 11.9% based on the past 8 years of stock performance.

Spyre Therapeutics Stock Rating

Buy
76
Spyre Therapeutics (SYRE) is a Buy

Is Spyre Therapeutics overpriced?

  • Spyre Therapeutics has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Spyre Therapeutics Stock Price History

Is SYRE stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SYRE is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
spyre.com

52-Week Data

52-Week High:
47.97
52-Week Low:
8.43

Prediction Charts

Market Cap:
1.72B
Price in USD:
33.80
Volume:
311.98K
Beta:
2.54

Technical Analysis

SMA50:
29.22
SMA100:
28.59
SMA200:
30.56
52-Wk Change:
217.07%

Stock Predictions

  • Is Spyre Therapeutics stock public?
    Yes, Spyre Therapeutics is a publicly traded company.
  • What is the Spyre Therapeutics stock quote today?
    The Spyre Therapeutics stock price is 33.80 USD today.
  • How to buy Spyre Therapeutics stock online?
    You can buy Spyre Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-9 27.85 27.50 28.30 26.75
Oct-10 27.01 27.22 27.34 26.28
Oct-11 27.21 28.70 28.96 27.15
Oct-14 28.41 30.66 30.70 28.30
Oct-15 31.21 31.48 32.00 29.80
Oct-16 31.00 32.37 32.45 30.61
Oct-18 32.75 32.76 33.27 31.89
Oct-21 32.67 32.43 33.14 31.70
Oct-22 32.26 34.15 34.21 32.19
Oct-23 34.00 33.61 34.70 32.22
Oct-24 33.86 33.70 34.46 33.37
Oct-25 34.94 34.81 36.60 34.14
Oct-28 35.49 34.40 36.09 34.29
Oct-29 34.30 33.80 34.70 32.91

Spyre Therapeutics Earnings

Spyre Therapeutics Earnings Report: Per Share Spyre Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Spyre Therapeutics Forecast Revenue Growth

Spyre Therapeutics Stock Analysis: Historical quarterly revenues per share for Spyre Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.01 per share, and a decrease next year of $0.09 per share.

* Spyre Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.